Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol Facilitates Micellar Solubilization In Vitro, but In Vivo Performance Remains Superior with Pure Sesame Oil Vehicle

Oral sesame oil-based formulation facilitates the delivery of poorly water-soluble drug cannabidiol (CBD) to the lymphatic system and blood circulation. However, this natural oil-based formulation also leads to considerable variability in absorption of CBD. In this work, the performance of lipid-based formulations with the addition of medium-chain triglyceride (MCT) or surfactants to the sesame oil vehicle has been tested in vitro and in vivo using CBD as a model drug.

The in vitro lipolysis has shown that addition of the MCT leads to a higher distribution of CBD into the micellar phase. Further addition of surfactants to MCT-containing formulations did not improve distribution of the drug into the micellar phase. In vivo, formulations containing MCT led to lower or similar concentrations of CBD in serum, lymph and MLNs, but with reduced variability. MCT improves the emulsification and micellar solubilization of CBD, but surfactants did not facilitate further the rate and extent of lipolysis. Even though addition of MCT reduces the variability, the in vivo performance for the extent of both lymphatic transport and systemic bioavailability remains superior with a pure natural oil vehicle.

See the article here

or download the full research paper as pdf: Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol

Materials

Sesame oil, glyceryl trioctanoate, polyoxyethylenesorbitan trioleate (Tween^® 85, Sigma-Aldrich, Dorset, UK), polyethylene glycol sorbitan monooleate (Tween^® 80), sorbitan monolaurate (Span^® 20, Sigma-Aldrich, Dorset, UK), d-α-Tocopherol polyethylene glycol 1000 (TPGS), sodium hydroxide solution (NaOH, 1 M), l-α-phosphatidylcholine (~60%, from egg yolk), Trizma^® (Sigma-Aldrich, Dorset, UK) maleate, sodium taurocholate hydrate, pancreatin from porcine pancreas (8 × USP specifications), sodium taurocholate hydrate, probucol, 4,4-dichlorodiphenyltrichloroethane (DDT) and serum triglyceride determination kit were all purchased from Sigma-Aldrich (Dorset, UK). Sodium chloride and anhydrous calcium chloride were purchased from Fisher Scientific (Leicester, UK). Cannabidiol (CBD, ≥98%) was purchased from THC Pharm (Frankfurt, Germany). Rat plasma was purchased from Sera Laboratories International (West Sussex, UK). All solvents were purchased from Fisher Scientific (Leicester, UK), and were of HPLC grade.

Feng, W.; Qin, C.; Cipolla, E.; Lee, J.B.; Zgair, A.; Chu, Y.; Ortori, C.A.; Stocks, M.J.; Constantinescu, C.S.; Barrett, D.A.; Fischer, P.M.; Gershkovich, P. Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol Facilitates Micellar Solubilization In Vitro, but In Vivo Performance Remains Superior with Pure Sesame Oil Vehicle. Pharmaceutics 2021, 13, 1349. https://doi.org/10.3390/pharmaceutics13091349

Excipients for CBD NEW2 — Excipients for CBD formulation

Tags: excipients formulation

Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol Facilitates Micellar Solubilization In Vitro, but In Vivo Performance Remains Superior with Pure Sesame Oil Vehicle

Related Posts

Application of AI in Tablet Development: An Integrated Machine Learning Framework for Pre-Formulation Property Prediction

Hydroxypropyl Methylcellulose Capsules Enhance Aerodynamic Performance of Carrier-Based Dry Powder Inhaler Formulations: A Comprehensive Evaluation of Capsule Material Effects

Patient-friendly dosage forms: the potential of galenIQ™ in formulations of lozenges

Utilization of Ethylcellulose Microparticles with Rupatadine Fumarate in Designing Orodispersible Minitablets with Taste Masking Effect

Cart

Shop Search

Top Pharma-Excipient Links

Welcome Back!

Retrieve your password